Lenvatinib Suppresses Angiogenesis through the Inhibition of both the VEGFR and FGFR Signaling Pathways

Lenvatinib Suppresses Angiogenesis through the Inhibition of both the VEGFR and FGFR Signaling Pathways

<p>Lenvatinib mesilate (lenvatinib) is an oral multiple-receptor tyrosine kinase inhibitor that selectively inhibits the kinase activities of Vascular Endothelial Growth Factor Receptor (VEGFR) 1-3, Fibroblast Growth Factor Receptor (FGFR) 1-4, Platelet-Derived Growth Factor Receptor (PDGFR) α...

Full description

Saved in:
Bibliographic Details
Main Authors: Kenji Ichikawa (Author), Saori Watanabe Miyano (Author), Yusuke Adachi (Author), Masahiro Matsuki (Author), Kiyoshi Okamoto (Author), Junji Matsui (Author)
Format: Book
Published: Global Journal of Cancer Therapy - Peertechz Publications, 2016-07-02.
Subjects:
Research Article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items